FARMACIA Y SALUD
Escuela de doctorado
University of Sydney
Sídney, AustraliaPublicaciones en colaboración con investigadores/as de University of Sydney (9)
2023
-
Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: An international multicentre analysis
CMAJ. Canadian Medical Association Journal, Vol. 66, Núm. 3, pp. E310-E320
-
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
British Journal of Cancer, Vol. 128, Núm. 12, pp. 2283-2294
-
Profiling the immune landscape in mucinous ovarian carcinoma
Gynecologic Oncology, Vol. 168, pp. 23-31
-
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Journal of Pathology: Clinical Research, Vol. 9, Núm. 3, pp. 208-222
2021
-
Identification of a locus near ULK1 associated with progression-free survival in ovarian cancer
Cancer Epidemiology Biomarkers and Prevention, Vol. 30, Núm. 9, pp. 1669-1680
2020
-
Prognostic gene expression signature for high-grade serous ovarian cancer
Annals of Oncology, Vol. 31, Núm. 9, pp. 1240-1250
2019
-
Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing Recommendations
Clinical Pharmacokinetics, Vol. 58, Núm. 6, pp. 767-780
2017
-
Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci
Oncotarget, Vol. 8, Núm. 39, pp. 64670-64684
2015
-
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer
Clinical Cancer Research, Vol. 21, Núm. 3, pp. 652-657